12-45850887-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_152641.4(ARID2):​c.2764A>G​(p.Thr922Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0013 in 1,614,066 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0070 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00071 ( 11 hom. )

Consequence

ARID2
NM_152641.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3O:1

Conservation

PhyloP100: -1.70

Publications

8 publications found
Variant links:
Genes affected
ARID2 (HGNC:18037): (AT-rich interaction domain 2) This gene encodes a member of the AT-rich interactive domain (ARID)-containing family of DNA-binding proteins. Members of the ARID family have roles in embryonic patterning, cell lineage gene regulation, cell cycle control, transcriptional regulation and chromatin structure modification. This protein functions as a subunit of the polybromo- and BRG1-associated factor or PBAF (SWI/SNF-B) chromatin remodeling complex which facilitates ligand-dependent transcriptional activation by nuclear receptors. Mutations in this gene are associated with hepatocellular carcinomas. A pseudogene of this gene is found on chromosome1. [provided by RefSeq, Dec 2016]
ARID2 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
  • Coffin-Siris syndrome 6
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0029337108).
BP6
Variant 12-45850887-A-G is Benign according to our data. Variant chr12-45850887-A-G is described in ClinVar as Benign. ClinVar VariationId is 133562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00703 (1070/152204) while in subpopulation AFR AF = 0.0243 (1011/41524). AF 95% confidence interval is 0.0231. There are 10 homozygotes in GnomAd4. There are 489 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1070 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID2NM_152641.4 linkc.2764A>G p.Thr922Ala missense_variant Exon 15 of 21 ENST00000334344.11 NP_689854.2
ARID2NM_001347839.2 linkc.2764A>G p.Thr922Ala missense_variant Exon 15 of 20 NP_001334768.1 Q68CP9
ARID2XM_047428489.1 linkc.2764A>G p.Thr922Ala missense_variant Exon 15 of 17 XP_047284445.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID2ENST00000334344.11 linkc.2764A>G p.Thr922Ala missense_variant Exon 15 of 21 1 NM_152641.4 ENSP00000335044.6 Q68CP9-1

Frequencies

GnomAD3 genomes
AF:
0.00703
AC:
1069
AN:
152086
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00623
GnomAD2 exomes
AF:
0.00194
AC:
487
AN:
251400
AF XY:
0.00131
show subpopulations
Gnomad AFR exome
AF:
0.0268
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000704
Gnomad OTH exome
AF:
0.000978
GnomAD4 exome
AF:
0.000707
AC:
1033
AN:
1461862
Hom.:
11
Cov.:
32
AF XY:
0.000598
AC XY:
435
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0246
AC:
824
AN:
33478
American (AMR)
AF:
0.00139
AC:
62
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000297
AC:
33
AN:
1111988
Other (OTH)
AF:
0.00172
AC:
104
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
81
162
243
324
405
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00703
AC:
1070
AN:
152204
Hom.:
10
Cov.:
32
AF XY:
0.00657
AC XY:
489
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0243
AC:
1011
AN:
41524
American (AMR)
AF:
0.00275
AC:
42
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68002
Other (OTH)
AF:
0.00616
AC:
13
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00241
Hom.:
7
Bravo
AF:
0.00838
ESP6500AA
AF:
0.0252
AC:
111
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00245
AC:
298
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:3Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ARID2-related disorder Benign:1
Jul 18, 2022
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not specified Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.74
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.23
DANN
Benign
0.75
DEOGEN2
Benign
0.012
T;T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.61
T;.;T
MetaRNN
Benign
0.0029
T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.34
N;.;.
PhyloP100
-1.7
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.080
N;N;N
REVEL
Benign
0.054
Sift
Benign
0.46
T;T;T
Sift4G
Benign
0.84
T;T;T
Polyphen
0.0
B;.;B
Vest4
0.084
MVP
0.27
MPC
0.12
ClinPred
0.0025
T
GERP RS
-4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.032
gMVP
0.079
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs114470162; hg19: chr12-46244670; COSMIC: COSV57610947; COSMIC: COSV57610947; API